NKX3.1 Expression Contributes to Epithelial–Mesenchymal Transition of Prostate Cancer Cells
ACS Omega · 12.09.2023 · 8 (36) · 32580-32592
DOI: 10.1021/acsomega.3c03127 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 01.09.2023. Verfasst von Iroda Saydullaeva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Engineering, Department of Bioengineering, Cancer Biology Laboratory, Ege University, Izmir 35040, Turkey. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Engineering, Department of Bioengineering, Cancer Biology Laboratory, Ege University, Izmir 35040, Turkey.
- Faculty of Pharmacy, Department of Pharmaceutical Biotechnology, Ege University, Izmir 35040, Turkey.
ORCID-Profile: Kemal Sami Korkmaz
Förderung
- T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu
Zitieren
APA
Saydullaeva, I., Butuner, B. D., & Korkmaz, K. S. (2023). NKX3.1 Expression Contributes to Epithelial–Mesenchymal Transition of Prostate Cancer Cells. ACS Omega, 8(36), 32580-32592. https://doi.org/10.1021/acsomega.3c03127
Vancouver
Saydullaeva I, Butuner BD, Korkmaz KS. NKX3.1 Expression Contributes to Epithelial–Mesenchymal Transition of Prostate Cancer Cells. ACS Omega. 2023;8(36):32580-32592. doi:10.1021/acsomega.3c03127
BibTeX
@article{Saydullaeva2023,
author = {Saydullaeva, Iroda and Butuner, Bilge Debelec and Korkmaz, Kemal Sami},
title = {NKX3.1 Expression Contributes to Epithelial–Mesenchymal Transition of Prostate Cancer Cells},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {36},
pages = {32580--32592},
doi = {10.1021/acsomega.3c03127}
}
EUVIMED